Experts to Debut Society’s Center on Obesity and New Scientific Statement 

Published on September 4, 2026

Members will get a first look at the Society’s new Center on Obesity as well as the Scientific Statement, “Obesity Science, Research Gaps and Opportunities in the New Era of Obesity Medicines,” during a virtual event September 9.  Daniel J. Drucker, MD, a pioneer in the development of GLP-1RA therapies and leader of the writing […]

The post Experts to Debut Society’s Center on Obesity and New Scientific Statement  appeared first on Endocrine News.

Continue reading on website
Other news

New Offerings Demonstrate the Endocrine Society’s Leadership Role in Obesity Space

September 4, 2026
Rising obesity rates are a concern around the world, as any glance at the news headlines will tell you. Clinicians, researchers, public health authorities, healthcare payers, and citizens alike are seeking solutions to the many health, economic, and societal consequences of this chronic disease. At the same time, remarkable new drugs are offering opportunities to […]The post New Offerings Demonstr

Pharma Friday – September 4, 2026

September 4, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer On August 26, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients […]The post Pharma